# Abeona Therapeutics (ABEO) — Earnings

ABEO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/abeo/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.35 |
| EPS estimate | −$0.23 |
| EPS surprise | −51.06% |
| Revenue surprise | −7.01% |
| Revenue | $11.4M |
| Revenue estimate | $12.2M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/318306/000149315226037576/form10-q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/3b6f302f-9130-f219-91dd-bcbf105c9324.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | −$0.23 | −$0.35 | -51.06% | $12.2M | $11.4M |
| Q1 2026 | May 13, 2026 | −$0.34 | −$0.30 | 10.45% | $4.6M | $8.7M |
| Q4 2025 | Mar 17, 2026 | −$0.35 | −$0.36 | -2.27% | $4.4M | $5.4M |
| Q3 2025 | Nov 12, 2025 | −$0.28 | −$0.10 | 64.54% | $5.2M | — |
| Q2 2025 | Aug 14, 2025 | −$0.39 | $1.71 | 538.46% | — | $400,000.00 |
| Q1 2025 | May 15, 2025 | −$0.36 | −$0.24 | 32.96% | — | — |
| Q4 2024 | Mar 20, 2025 | −$0.35 | $0.50 | 243.68% | $100,000.00 | — |
| Q3 2024 | Nov 14, 2024 | −$0.40 | −$0.63 | -55.94% | $100,000.00 | — |
| Q2 2024 | Aug 12, 2024 | −$0.34 | −$0.26 | 23.98% | $100,000.00 | — |
| Q1 2024 | May 15, 2024 | −$0.51 | −$1.16 | -125.99% | $166,667.00 | — |
| Q4 2023 | Mar 18, 2024 | −$0.47 | −$0.59 | -25.53% | — | — |
| Q3 2023 | Nov 13, 2023 | −$0.53 | −$0.48 | 9.99% | — | — |
| Q2 2023 | Aug 8, 2023 | −$0.67 | −$0.92 | -36.64% | — | $3.5M |
| Q1 2023 | May 11, 2023 | −$0.61 | −$0.54 | 11.48% | — | — |
| Q4 2022 | Mar 29, 2023 | −$0.75 | −$0.06 | 91.51% | $1.0M | $68,000.00 |
| Q3 2022 | Nov 14, 2022 | −$1.75 | −$1.48 | 15.27% | — | — |
| Q2 2022 | Aug 11, 2022 | −$1.88 | −$2.08 | -10.93% | — | $1.0M |
| Q1 2022 | May 13, 2022 | −$2.38 | −$3.50 | -47.37% | — | $346,000.00 |
| Q4 2021 | Mar 31, 2022 | −$3.67 | −$11.25 | -206.82% | — | $3.0M |
| Q3 2021 | Nov 15, 2021 | −$4.00 | −$1.75 | 56.25% | — | — |

## Frequently Asked Questions

### When did Abeona Therapeutics (ABEO) last report earnings?

Abeona Therapeutics last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did ABEO beat earnings estimates?

No. Abeona Therapeutics reported EPS of −$0.35 for Q2 2026 against a −$0.23 estimate — a 51.06% miss.

### How much revenue did ABEO report last quarter?

Abeona Therapeutics reported $11.4M in revenue for Q2 2026, against a consensus estimate of $12.2M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).